Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

K92 Mining Inc T.KNT

Alternate Symbol(s):  KNTNF

K92 Mining Inc. is a Canada-based company, which is engaged in the production of gold, copper and silver at the Kainantu Gold Mine in the Eastern Highlands province of Papua New Guinea, as well as exploration and development of mineral deposits in the immediate vicinity of the mine, including Blue Lake, in Papua New Guinea. The Company holds the mining rights to Mining Lease 150 (ML 150). Within and surrounding ML 150 is an epithermal vein field consisting of multiple known and highly prospective vein systems: Kora, Irumafimpa, Karempe, Judd, Kora South, Judd South, Mati, Maniape and Arakompa. Mining is focused on the Kora vein system, consisting of two dominant veins and the Judd vein system consisting of four known veins with one vein being mined. There are multiple near-mine infrastructure targets, within the Kora-Kora South, Judd-Judd South and Karempe vein systems.


TSX:KNT - Post by User

Post by tuesdaynightridon Aug 05, 2024 2:59pm
252 Views
Post# 36164892

KNT 2nd Q earnings Call - What Matters

KNT 2nd Q earnings Call - What Matters

The earnings call will take place on 8/13/2024.
The 2nd q gold price was nearly $300 higher than 1st q but only
19k AU eq oz was sold... so I expect eps to be anywhere from
-0.01 to +0.03 eps. It will be interesting to see if they keep AISC is below
$1500 w an inefficient 19k AU eq sold. Who knows?
if KNT meets their downward revision of 120k AU eq oz for whole year then
they will average 35k au eq oz for both remaining quarters..
This should result in a very positive eps for 3rd and 4th q... but not now.

The important thing now is for analysts to focus on detailed questions regarding
stage 3 and 4 development status.

1.) The stage 3, 290k oz schedule has changed from end 1st q to later in 2025.
What is the new stage 3 completion schedule? Note, 72k AU eq oz  per quarter
will result once steady state ramp up is completed?.
2.) Revised stage 4, 470k oz 2026 schedule?
3.) What is the current debt/financing looking like? In 1st q, 2023, knt stated
stage 3 cap ex at $178M and stage 4 at $187M. They have been paying
on both through cash flow so where are we now? No update since 1/2023.
4.)What is the $120M financing plan for stage 3 and 4 debt. If 1st draw payback
does not have to begin until 4 years later, then cash flow by 2026 should easily
cover.... ask Lewins to explain his plan.

In short, analysts need to engage knt in more detailed discussion and timelines
than prior calls. A timeline on resource update wouldn't either.

<< Previous
Bullboard Posts
Next >>